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INTRODUCTION
Fully grown mammalian oocytes are held in meiotic prophase arrest
by a signal from the surrounding somatic cells of the ovarian follicle.
The outer layers of somatic cells (mural granulosa), rather than the
inner cumulus cells that directly surround the oocyte, are considered
to be the primary source of the meiosis-inhibitory signal, as removal
of oocytes or cumulus-oocyte complexes from the follicle causes
meiosis to resume (Pincus and Enzmann, 1935). The mural
granulosa cells are also the site of action of luteinizing hormone
(LH), which is the physiological stimulus for the prophase-to-
metaphase transition (Eppig et al., 2004; Mehlmann, 2005a; Jones,
2008).
Maintenance of prophase arrest also requires elevated cAMP
levels in the oocyte (Cho et al., 1974; Masciarelli et al., 2004). The
oocyte generates cAMP by way of a constitutively active
heterotrimeric G protein (Gs)-linked receptor, GPR3 or GPR12,
which acts to stimulate adenylyl cyclase (Mehlmann et al., 2002;
Mehlmann et al., 2004; Horner et al., 2003; Freudzon et al., 2005;
Hinckley et al., 2005; Ledent et al., 2005; Mehlmann, 2005b).
cAMP maintains meiotic prophase arrest by way of protein kinase
A (PKA)-mediated phosphorylation of proteins that regulate cyclin-
dependent protein kinase (Jones, 2008).
cAMP levels in the oocyte decrease with time after its removal
from the follicle (Vivarelli et al., 1983; Törnell et al., 1990a),
indicating that the somatic cells contribute to maintaining elevated
cAMP in the oocyte. Isolation of the oocyte does not decrease Gs
activation by GPR3, indicating that the meiosis-inhibitory signal is
not a GPR3 agonist (Freudzon et al., 2005). Instead, the signal
appears to act by way of gap junctions between the somatic cells and
oocyte because reducing junctional communication causes oocyte
cAMP to decrease and meiosis to resume (Sela-Abramovich et al.,
2006; Norris et al., 2008).
One possibility is that the signal that maintains meiotic arrest is
cAMP that diffuses from the somatic cells to the oocyte (Anderson
and Albertini, 1976) (see Discussion). Alternatively, because the
primary cAMP phosphodiesterase in the oocyte is PDE3A
(Masciarelli et al., 2004), which is inhibited by cGMP (Hambleton
et al., 2005), cGMP from the somatic cells could enter the oocyte
through the gap junctions, thus inhibiting PDE3A and maintaining
meiotic arrest (Törnell et al., 1991). Consistent with this hypothesis,
cGMP in the oocyte decreases as a function of time after isolation of
the oocyte from the follicle, and injection of cGMP into the oocyte
delays meiotic resumption (Törnell et al., 1990a). Inhibition of
soluble guanylyl cyclase (Sela-Abramovich et al., 2008) or of
inosine monophosphate dehydrogenase (needed for cGMP
production) (Downs and Eppig, 1987; Eppig, 1991) causes meiotic
resumption in follicle-enclosed oocytes, indicating that production
of cGMP in the follicle is essential for the maintenance of meiotic
arrest.
However, the hypothesis that cGMP from the somatic cells
maintains meiotic arrest has not been directly tested; it is unknown
whether gap junction closure lowers cGMP in the oocyte, or whether
lowering oocyte cGMP lowers cAMP levels sufficiently to trigger
meiotic resumption. It has also been proposed that instead of cGMP,
phosphorylation could be the primary regulator of PDE3A in the
oocyte (Han et al., 2006). Here, we directly test the possible role of
cGMP in maintaining meiotic arrest.
Whether LH causes cAMP and cGMP in the oocyte to decrease
to a level that allows meiotic resumption, and if so how this occurs,
have also been uncertain. LH causes a rapid and almost complete
closure of the gap junctions between the somatic cells in the follicle
(Norris et al., 2008), such that if cGMP from the somatic cells enters
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the oocyte prior to LH stimulation, the gap junction closure in
response to LH should decrease cGMP, and indirectly cAMP, in the
oocyte. In mouse and rat oocytes isolated from follicles after LH
receptor stimulation, immunoassays have shown that cAMP has
decreased (Schultz et al., 1983; Sela-Abramovich et al., 2006).
However, the magnitude of these changes was difficult to interpret
because the oocytes were removed from their follicles, which would
decrease cAMP, and because phosphodiesterase inhibitors were
present, which would increase cAMP. Thus, it is unknown whether
the decreases in cAMP that were observed in response to LH
receptor stimulation were sufficient to affect the activity of PKA,
which requires cAMP in the range of 70-500 nM for half-maximal
activity (Dostmann and Taylor, 1991; Viste et al., 2005). LH-
stimulated decreases in cGMP occur in oocytes and whole follicles
from hamsters (Hubbard, 1986), but whether the magnitude of these
changes is physiologically significant and whether these decreases
occur in other species are unknown. These are crucial issues
because, as noted above, cGMP is not the only regulator of PDE3A;
in addition, it is controversial whether relief of inhibitory signals
from the somatic cells is the primary mode of LH action (see Eppig
et al., 2004).
Because follicle integrity is essential for regulating oocyte cAMP
and cGMP, understanding the function of cyclic nucleotides in the
oocyte requires measurements within the intact follicle. Optical
indicators based on Förster resonance energy transfer (FRET)
(Nikolaev and Lohse, 2006; Nikolaev et al., 2006; Russwurm et al.,
2007; Willoughby and Cooper, 2008) are ideal for this purpose.
These sensors have been used in mouse oocytes (Webb et al., 2002;
Webb et al., 2008), although not in oocytes within antral follicles.
The sensor used in those studies, comprising fluorescent catalytic
and regulatory subunits of PKA, has the disadvantage of inhibiting
meiotic progression (Webb et al., 2002), probably because it elevates
PKA activity (Goaillard et al., 2001). Other available sensors are not
optimal for investigation of cAMP changes that control PKA-
mediated events because their dynamic ranges do not correspond to
that of PKA (Nikolaev and Lohse, 2006).
In the present study we developed a more sensitive FRET-based
cAMP sensor and used it, as well as a cGMP sensor, to measure
cAMP and cGMP in living follicle-enclosed mouse oocytes. We
show that in response to LH, concentrations of both cAMP and
cGMP decrease in the oocyte prior to nuclear envelope breakdown
(NEBD) and within concentration ranges that are physiologically
significant for regulation of PKA and PDE3A. The level of cGMP
in the somatic cells of the follicle decreases in parallel. By injecting
specific phosphodiesterases that hydrolyze cAMP and cGMP, and
by applying inhibitors that control gap junction communication, we
establish that cGMP from the somatic cells is essential for
maintaining meiotic arrest and that LH causes meiosis to resume by
reversing this inhibitory pathway.
MATERIALS AND METHODS
cAMP and cGMP sensors
To develop a FRET-based sensor with increased affinity for cAMP, we
introduced a K405E point mutation into the EPAC2 (RAPGEF4) sequence
of the previously described Epac2-camps sensor, which consists of yellow
fluorescent protein (YFP) and cyan fluorescent protein (CFP) linked by the
cAMP-binding domain of EPAC2 (Nikolaev et al., 2004) (Fig. 1A). Similar
mutation of the homologous residue Q270 in EPAC1 (RAPGEF3) increases
the affinity for cAMP by ~2.5-fold (Dao et al., 2006). This new sensor,
Epac2-camps300, was expressed in Sf9 cells and purified using Ni-NTA
agarose (Qiagen, Valencia, CA, USA) and heparin sepharose; the protein
was more than 90% pure.
In vitro measurements with the Epac2-camps and Epac2-camps300
sensors were performed as previously described (Nikolaev et al., 2004), with
purified protein diluted in 5 mM Tris, 2 mM EDTA (pH 7.4) to a final
concentration of 50 nM. The EC50 value for Epac2-camps in this buffer
(~800-900 nM; Fig. 1B) (Nikolaev et al., 2004) was close to that previously
determined in a buffer more closely resembling the cytosol (1100 nM)
(Iancu et al., 2008). Emission spectra were measured using a fluorescence
spectrometer (LS50B, Perkin Elmer Life Sciences, Waltham, MA, USA)
with 436 nm excitation. YFP/CFP emission ratios were calculated by
dividing fluorescence intensities measured at the 527 and 478 nm peaks, and
were corrected for the spectral bleed-through of CFP into the YFP channel.
The cGi500 sensor for cGMP, which consists of YFP and CFP linked by
the tandem cGMP-binding domains of cGMP-dependent protein kinase I,
was constructed as previously described (Russwurm et al., 2007).
Fluorescence spectra of the cGi500 sensor were measured using the
supernatant from a homogenate of transiently transfected HEK293a cells in
5 mM Tris, 2 mM EDTA (pH 7.4) (see Fig. S1 in the supplementary
material). The EC50 value in this buffer (~350 nM) was close to that reported
in a higher ionic strength, chloride buffer (500 nM) (Russwurm et al., 2007).
For microinjection, cGi500 RNA was post-transcriptionally polyadenylated
(see Freudzon et al., 2005) and injected into oocytes at a final concentration
of 40-100 μg/ml.
Culture and microinjection of antral follicle-enclosed mouse
oocytes
Antral follicles with their associated theca cells (see Norris et al., 2008) were
dissected from 22- to 24-day-old B6SJLF1 mice (Jackson Laboratory, Bar
Harbor, ME, USA), as approved by the University of Connecticut Animal
Care Committee. They were cultured for 24-32 hours on Millicell culture
plates (PICMORG50, Millipore, Billerica, MA, USA) in media as
previously described (Norris et al., 2008). Ovine LH (from A. F. Parlow,
National Hormone and Peptide Program, Torrance, CA, USA) was used at
10 μg/ml. Quantitative microinjection of 4 or 10 pl (equivalent to 2 or 5%
of the 200 pl volume of the oocyte) was carried out as previously described,
with the follicles held between two coverslips spaced 200 μm apart (Jaffe
and Terasaki, 2004; Jaffe et al., 2009). Follicles were kept in the injection
slide for no more than 30 minutes; between injections, they were returned to
Millicell culture plates. Proteins for injection were spin-dialyzed and
concentrated in PBS.
Measurements of cAMP and cGMP in follicle-enclosed oocytes
FRET measurements were made 2.5-10 hours after injecting follicle-
enclosed oocytes with Epac2-camps300 protein, or 19-26 hours after
injecting cGi500 RNA. We used a Zeiss Pascal confocal system with a
20/0.5 NA Neofluar objective, and a 440 nm laser (Toptica Photonics,
Victor, NY, USA) for excitation. YFP and CFP emission filters were from
Chroma Technology (Rockingham, VT, USA; HQ535/50M and
HQ480/40M, with a 510DCLP dichroic). The microscope was focused on
the oocyte equator, with the confocal pinhole set for a ~30 μm optical
section. Images were collected at 2-10 second intervals. The laser
attenuation was adjusted to avoid saturation. The follicles were held in an
injection slide as described above, with humidified 5% CO2 in air flowing
through the chamber on the microscope stage at 30-34°C (see Jaffe et al.,
2009).
YFP and CFP intensities were measured within a circular region of
interest that was slightly smaller than the oocyte diameter. The percentage
change in the YFP/CFP emission ratio following injection of cAMP or
cGMP was calculated from values averaged over a 2-minute period before
injection and over a 20-second period after injection. Measurements were
corrected for minor autofluorescence and for spectral bleed-through of CFP
into the YFP channel. Data analysis used the following software:
MetaMorph (Molecular Devices, Downingtown, PA, USA), Excel
(Microsoft, Redmond, WA, USA), Origin (OriginLab, Northampton, MA,
USA) and InStat (GraphPad Software, San Diego, CA, USA). Data are
reported as mean±s.e.m.; n=the number of oocytes tested. P-values were
determined using an unpaired Student’s t-test. The cAMP hydrolytic activity
of PDE3A was calculated using the following equation for Michaelis-











Menten kinetics with cGMP as a competitive inhibitor (see Cook and
Cleland, 2007) and values for Km and Ki from Hambleton et al. (Hambleton
et al., 2005): V/Vmax=[cAMP]/{Km(1+[cGMP]/Ki)+[cAMP]}.
PDE3A, PDE9A, CX37 antibody and other reagents
The catalytic domain (amino acids 665-1141) of human PDE3A was purified
from bacteria. The protein was more than 90% pure and its activity, as
assayed at 0.2 μM cAMP, was ~0.2 μmoles/minute/mg. Results similar to
those described here were also obtained with a partially purified preparation
of a form of PDE3A lacking the membrane-association region (PDE3A-94)
(Hambleton et al., 2005). The catalytic domain (amino acids 181-506) of
human PDE9A was purified from bacteria (Huai et al., 2004). The protein
was more than 90% pure and had a Vmax of 1.5 μmoles/minute/mg. A D293A
point mutation in the PDE9A catalytic domain caused a 10,000-fold
decrease in activity. An affinity-purified antibody against the C-terminal
domain of CX37 was provided by Alex Simon (University of Arizona)
(Simon et al., 2006). Cyclic nucleotides, ATP, carbenoxolone, milrinone and
BSA were obtained from Sigma-Aldrich (St Louis, MO, USA), U0126 from
EMD Chemicals (La Jolla, CA, USA) and non-immune IgG from Santa
Cruz Biotechnology (Santa Cruz, CA, USA).
cGMP content of whole follicles
Antral follicles were dissected and cultured as described above. After
washing in PBS, groups of ~20 follicles were solubilized in 100 μl 0.1 M
HCl, sonicated, heated at 95°C for 2 minutes, then stored at –80°C before
being analyzed using a cGMP immunoassay kit (Sigma-Aldrich, CG200);
the cross-reactivity of this assay with GMP, GTP, cAMP and ATP is
negligible (Sigma product information). The cellular volume per follicle
was estimated to be ~20 nl, based on an average follicle diameter of
~360 μm; of the antral follicle volume, ~10% was estimated to be antral
space.
RESULTS
Epac2-camps300, a new cAMP sensor that
responds in the cAMP concentration range that
regulates PKA
To determine whether LH reduces oocyte cAMP to a level that lowers
PKA activity, we developed a new sensor, Epac2-camps300 (Fig. 1A),
which shows 50% of its maximum change in the YFP/CFP emission
ratio (EC50) at ~320 nM cAMP (Fig. 1B), which is in the concentration
range that half-maximally activates PKA enzymes. Epac2-camps300
was produced by making a K405E point mutation in the previously
described Epac2-camps (Nikolaev et al., 2004), which has an EC50 of
~820 nM for cAMP (Fig. 1B). Epac2-camps300 was highly specific
for cAMP, with an EC50 of ~14 μM for cGMP (Fig. 1C). ATP at 10
mM had no effect on Epac2-camps300 FRET. The cGMP
concentration in mouse oocytes is ~900 nM (see below) and the ATP
concentration is ~1 mM (Johnson et al., 2007). Thus, cytoplasmic
cGMP and ATP should not interfere with the use of this sensor to
measure changes in cAMP in the oocyte cytoplasm.
Measurement of cAMP changes in follicle-
enclosed mouse oocytes
To establish a method for live cell measurements of changes in
cAMP in antral follicle-enclosed oocytes, we microinjected the
oocytes with Epac2-camps300 protein. Using a confocal
microscope, we excited CFP and measured the ratio of YFP to CFP
emission as an indicator of the concentration of cAMP in the oocyte
(Fig. 2). To avoid variability due to the differing optical properties
of individual follicles, we standardized each measurement by
subsequently injecting 1 mM cAMP to saturate the sensor. This
provided a measure of the percentage change in the YFP/CFP
emission ratio between the baseline concentration of cAMP and that
at the maximum of the concentration-response curve (Fig. 3A). The
percentage change was the same using 2 or 5 μM sensor, indicating
that the 5 μM Epac2-camps300 we used did not alter the basal
concentration of free cAMP in the oocyte (see Fig. S2A in the
supplementary material). Follicle-enclosed oocytes that were
injected with Epac2-camps300 resumed meiosis in response to LH,
and NEBD occurred with the same time course as in the absence of
the sensor, beginning at ~2 hours after LH application (see Fig. S3A
in the supplementary material).
LH causes a decrease in cAMP in the follicle-
enclosed oocyte before NEBD
To investigate the effect of LH on oocyte cAMP, we measured the
Epac2-camps300 YFP/CFP emission ratio from follicle-enclosed
oocytes. After determining this baseline ratio, the follicles were
injected with 1 mM cAMP to determine the percentage change in
the ratio in going from baseline to the cAMP-saturated condition.
For follicle-enclosed oocytes that had not been exposed to LH
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Fig. 1. In vitro characterization of the Epac2-camps300 sensor for
cAMP. (A) Diagram of the sensor, showing cyan fluorescent protein
(CFP, turquoise) and yellow fluorescent protein (YFP, yellow), linked by
the EPAC2 (RAPGEF4) cAMP-binding domain (red) [constructed based
on the crystal structures of EPAC2 (Protein Data Bank accession number
107F) and green fluorescent protein (Protein Data Bank accession
number 1GFL)]. The location of the K405E point mutation introduced
into the EPAC2 sequence of Epac2-camps to generate Epac2-camps300
is shown. Binding of cAMP decreases Förster resonance energy transfer
(FRET) between CFP and YFP. (B) Concentration-response curves for
Epac2-camps and Epac2-camps300 for cAMP. The EC50 (50% of the
maximum change in the YFP/CFP emission ratio) values are 820±130
nM (mean±s.e.m., n=7) for Epac2-camps, and 320±18 nM (n=6) for
Epac2-camps300. (C) Concentration-response curves for Epac2-












(basal), the YFP/CFP emission ratio changed by 15% (Fig. 3A,D).
By contrast, for follicles that had been exposed to LH for 1-1.4
hours, the ratio changed by 26% (Fig. 3B,D). For follicles exposed
to LH for 5 hours, the ratio changed by 33% (Fig. 3C,D). These
measurements showed that the concentration of cAMP in the
follicle-enclosed oocyte decreases in response to LH and that this
occurs before NEBD.
The cAMP decrease in response to LH occurs in a
concentration range that would decrease PKA
activity
To evaluate whether the cAMP decrease in response to LH occurs
in the regulatory range for PKA, we determined the absolute
concentrations of cAMP in follicle-enclosed oocytes before and
after LH exposure. For this purpose, we needed to know the
percentage change in the YFP/CFP emission ratio in the oocyte
over the dynamic range of the Epac2-camps300 sensor. We first
injected the catalytic domain of the high-affinity cAMP
phosphodiesterase PDE3A (Km=~90 nM) (Hambleton et al.,
2005) to lower cAMP to a minimum level. One hour later, we
injected 1 mM cAMP to saturate the sensor and measured the
percentage change in the YFP/CFP emission ratio. Using either
100 or 200 μg/ml PDE3A, the subsequent injection of 1 mM
cAMP caused the same change in the YFP/CFP emission ratio
(~36%, Fig. 4A,B), indicating that the amount of PDE3A used
was sufficient to obtain a maximum response, and that the change
in the YFP/CFP emission ratio over the dynamic range of Epac2-
camps300 in the oocyte is ~36%. We then used this value,
together with the concentration-response curve obtained in vitro
(Fig. 1B), to determine the concentrations of cAMP in the oocyte
before and after LH exposure (Fig. 4C).
Based on this analysis, the basal concentration of cAMP in antral
follicle-enclosed oocytes is ~660 nM (Fig. 4C). At 1-1.4 hours after
LH, the cAMP concentration is ~140 nM, and at 5 hours it is ~40 nM
(Fig. 4C). The cAMP decrease from ~660 to ~140 nM would
decrease the activity of PKA in the oocyte. Mouse oocytes contain
both PKAI and PKAII, although the relative amounts of these two
forms have not been determined (Newhall et al., 2006). PKAII is
half-maximally activated at ~500 nM cAMP (Dostmann and Taylor,
1991; Viste et al., 2005), and based on data in these publications a
decrease in cAMP from ~660 to ~140 nM would reduce the activity
of PKAII by 90%. PKAI activity would also decrease, although the
extent of this decrease is unknown, as values for the cAMP
concentrations that half-maximally activate PKAI vary from 70 to
500 nM depending on the type and concentration of the substrate
(Viste et al., 2005).
LH causes a decrease in cGMP in the follicle-
enclosed oocyte before NEBD and within a
concentration range that would increase PDE3A
activity
To investigate whether the concentration of cGMP in the follicle-
enclosed mouse oocyte decreases in response to LH, we used a
FRET-based cGMP sensor, cGi500 (Russwurm et al., 2007). cGi500
showed an EC50 of ~350 nM for cGMP and little or no response to
cAMP up to 20 μM (see Fig. S1 in the supplementary material)
(Russwurm et al., 2007). In follicle-enclosed oocytes that were
injected with cGi500 RNA and then cultured overnight, LH caused
meiotic resumption with the same time course as in the absence of
the sensor (see Fig. S3B in the supplementary material). The CFP
fluorescence of oocytes expressing this protein was close to that of
oocytes containing 5 μM Epac2-camps300, indicating that the
concentration of cGi500 was also in the range of 5 μM.
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Fig. 2. Confocal images of an antral follicle-enclosed oocyte
containing 5μM Epac2-camps300. The oil drop is present as a result
of microinjection. Upon excitation of CFP, the ratio of YFP to CFP
emission was measured as an indicator of the concentration of cAMP in
the oocyte.
Fig. 3. The concentration of cAMP in follicle-enclosed oocytes
decreases in response to luteinizing hormone. (A-C) The YFP/CFP
emission ratio from follicle-enclosed mouse oocytes containing Epac2-
camps300, before and after injecting 1 mM cAMP, for no treatment
(basal) (A) and for ~1 hour (B) or ~5 hours (C) after applying luteinizing
hormone (LH). (D) Percentage change in the YFP/CFP emission ratio in
response to injection of 1 mM cAMP for follicle-enclosed oocytes with
or without LH exposure. The percentage change was 15.1±1.8 (n=15)












For cGMP measurements, the YFP/CFP emission ratio was
determined for follicle-enclosed oocytes expressing cGi500. The
oocytes were injected with 1 mM cGMP to determine the
percentage change in the ratio. For follicles that had not been
exposed to LH (basal), the YFP/CFP emission ratio changed
by 14% (Fig. 5A,C). By contrast, for follicles that had been
exposed to LH for 1-1.3 or 5 hours, the ratio changed by 30%
(Fig. 5B,C). These measurements showed that LH causes a
decrease in cGMP in follicle-enclosed oocytes and that the
decrease precedes NEBD.
To calibrate the concentration of cGMP in the follicle-enclosed
oocyte, we used a similar procedure as for cAMP. To determine the
percentage change in the YFP/CFP emission ratio for cGi500 over
its dynamic range in vivo, we injected follicle-enclosed oocytes with
the catalytic domain of the high-affinity cGMP-specific
phosphodiesterase PDE9A (Km=140 nM) (Huai et al., 2004), and 1
hour later injected 1 mM cGMP (Fig. 6A). A similar percentage
change in the YFP/CFP emission ratio (~35%) was obtained with
injections of 180 or 360 μg/ml PDE9A, indicating that sufficient
PDE9A had been injected to obtain a maximum response (Fig. 6B).
Based on the calibration curve shown in Fig. 6C, the basal
concentration of free cGMP in the oocyte is ~900 nM. At 1-1.3 hours
and at 5 hours after LH application, the cGMP concentration is ~40
nM. Comparison of measurements from individual oocytes that
expressed somewhat different amounts of the cGi500 sensor showed
that the sensor did not alter the concentration of cGMP in the oocyte
(see Fig. S2B,C in the supplementary material).
1873RESEARCH ARTICLEMeiotic regulation by cyclic nucleotides
Fig. 4. Calibration of the cAMP concentrations in follicle-enclosed
oocytes with or without LH treatment. (A,B) Determination of the
percentage change in the YFP/CFP emission ratio for Epac2-camps300
in going from a minimum to a maximum cAMP concentration in vivo.
(A) Record from a follicle-enclosed mouse oocyte that was injected with
5μM Epac2-camps300 plus 100μg/ml PDE3A catalytic domain (to
lower cAMP to a minimum level), and then ~1 hour later injected with
1 mM cAMP. (B) Percentage change in YFP/CFP emission ratio in follicle-
enclosed oocytes injected with PDE3A, or BSA control, and then ~1
hour later injected with 1 mM cAMP. Injection of 100-200μg/ml PDE3A
lowered the YFP/CFP emission ratio by 35.5±1.0% (n=8). (C) cAMP
concentrations in follicle-enclosed oocytes with or without LH
treatment, as calculated using the in vitro concentration-response curve
for Epac2-camps300 (replotted here from Fig. 1B), the 35.5% value for
the maximum change in YFP/CFP emission ratio for Epac2-camps300 in
vivo (A,B), and the data presented in Fig. 3. The following example
illustrates how these calculations were made. For the measurement
shown in Fig. 3A, the change in YFP/CFP emission ratio in going from
the baseline level to that after injecting 1 mM cAMP was 14%. Using
the percentage change in YFP/CFP ratio over the dynamic range of the
sensor in vivo, shown above to be 35.5%, we calculated the
percentage change in YFP/CFP ratio corresponding to a change from ~0
mM cAMP to the baseline cAMP level in Fig. 3A: 35.5–14=21.5%.
21.5/35.5=61% of the maximum change in YFP/CFP ratio over the
dynamic range of the sensor. 61% on the y-axis of Fig. 4C corresponds
to 540 mM cAMP on the x-axis, as determined using Origin software.
The horizontal bars in C represent the mean±s.e.m. for the cAMP
concentrations calculated for the sets of measurements summarized in
Fig. 3D. Basal, 660±110 nM (n=15); 1-1.4 hours, 140±18 nM (n=18); 5
hours, 43±17 nM (n=5). The cAMP concentrations at 1-1.4 and 5 hours
after LH are significantly different from the basal value (P<0.0001 and
P=0.005, respectively), and from each other (P<0.01).
Fig. 5. The concentration of cGMP in follicle-enclosed oocytes
decreases in response to LH. (A,B) The YFP/CFP emission ratio from
follicle-enclosed mouse oocytes containing cGi500, before and after
injecting 1 mM cGMP, for no treatment (basal) (A) and for ~1 hour
after applying LH (B). (C) Percentage change in the YFP/CFP emission
ratio for cGi500 in response to injection of 1 mM cGMP, for follicle-
enclosed oocytes with or without LH treatment. The percentage change
in YFP/CFP emission ratio was 13.9±1.4 (n=21) for no LH, 30.1±0.6











The basal cGMP concentration in the oocyte of ~900 nM would
competitively inhibit the hydrolysis of cAMP by PDE3A, whereas
at the ~40 nM level after LH there would be less inhibition
(Hambleton et al., 2005). Based on the enzymatic properties of
PDE3A (Km for cAMP=90 nM; Ki for cGMP=20 nM) (Hambleton
et al., 2005), and at the initial cAMP concentration (~660 nM), the
drop in cGMP would increase cAMP-hydrolytic activity from 14 to
71% of the maximum (see Materials and methods). This 5-fold
increase in PDE3A activity would decrease oocyte cAMP, leading
to meiotic resumption.
Decreasing cGMP in follicle-enclosed oocytes
causes cAMP levels to decrease
To test directly whether decreasing cGMP would decrease cAMP in
the oocyte, we injected follicle-enclosed oocytes with a mixture of
the catalytic domain of PDE9A and the cAMP-specific sensor
Epac2-camps300. When measured ~1 hour later, cAMP in the
oocyte had decreased to ~50 nM (Fig. 7A,B). The effect was not due
to hydrolysis of cAMP by PDE9A because its Km for cAMP is 180
μM, which is more than 1000-fold higher than that for cGMP (140
nM), and its Vmax for cAMP is 20-fold lower than for cGMP (Huai
et al., 2004). These findings indicate that a high concentration of
cGMP is required to maintain the high concentration of cAMP in the
prophase-arrested oocyte, and that the decrease in cGMP in response
to LH is sufficient to decrease cAMP.
Decreasing cGMP in follicle-enclosed oocytes
causes PDE3-dependent meiotic resumption
The PDE9A catalytic domain caused NEBD within ~2 hours after
its injection into antral follicle-enclosed oocytes and the response
was concentration dependent (Fig. 8A). By contrast, a control
injection of a point-mutated form of PDE9A that lacks catalytic
activity (D293A) did not cause NEBD. NEBD was also stimulated
by injection of the catalytic domain of PDE3A, which hydrolyzes
cAMP and, at a lesser rate, cGMP (Lugnier, 2006) (Fig. 8B).
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Fig. 6. Calibration of cGMP concentrations in follicle-enclosed
oocytes with or without LH treatment. (A,B) Determination of the
percentage change in the YFP/CFP emission ratio for cGi500 in going
from a minimum to a maximum cGMP concentration in vivo. (A) Record
from a follicle-enclosed mouse oocyte containing cGi500 that was
injected with 360μg/ml PDE9A catalytic domain (to lower cGMP to a
minimum level) and ~1 hour later injected with 1 mM cGMP.
(B) Percentage change in YFP/CFP emission ratio in follicle-enclosed
oocytes injected with PDE9A, or BSA control, and then ~1 hour later
injected with 1 mM cGMP. Injection of 180-360μg/ml PDE9A lowered
the YFP/CFP emission ratio by 35.0±0.9% (n=16). (C) cGMP
concentrations in follicle-enclosed oocytes with or without LH
treatment, as calculated by the procedure described in the legend to
Fig. 4C, using the in vitro concentration-response curve for cGi500
(replotted here from Fig. S1 in the supplementary material), the 35.0%
value for the maximum change in YFP/CFP emission ratio for cGi500 in
vivo (A,B), and the data presented in Fig. 5. The horizontal bars in C
represent the mean±s.e.m. for the cGMP concentrations calculated for
the set of measurements summarized in Fig. 5C. Basal, 890±150 nM
(n=21); 1-1.3 hours, 39±7 nM (n=25); 5 hours, 30±5 nM (n=9); for
clarity, only the basal and 1-1.3 hour values are shown on the graph.
The cGMP concentrations at 1-1.3 and 5 hours after LH are significantly
different from the basal value (P<0.0001 and P=0.001, respectively),
but not from each other (P=0.5).
Fig. 7. Decreasing cGMP by injecting follicle-enclosed oocytes
with the catalytic domain of PDE9A decreases cAMP.
(A) Determination of the percentage change in the YFP/CFP emission
ratio for Epac2-camps300 in a follicle-enclosed mouse oocyte that was
injected with 180μg/ml PDE9A catalytic domain and then ~1 hour later
injected with 1 mM cAMP. The cAMP injection lowered the YFP/CFP
emission ratio by 31.2±0.7% (n=6). (B) cAMP concentrations after
injection of PDE9A, or BSA control (200μg/ml), determined using the
calibration curve in Fig. 4C. cAMP concentrations for basal and 1-1.4










PDE9A was only effective in causing meiotic resumption if
PDE3A in the oocyte was active; in the presence of the PDE3
inhibitor milrinone (Lugnier, 2006), which does not inhibit PDE9A
(Wunder et al., 2005), meiotic resumption in response to PDE9A
injection was reversibly inhibited (Fig. 8C). This result indicates that
the resumption of meiosis that occurs in response to a decrease in
cGMP results from alleviation of PDE3A inhibition by cGMP, rather
than through the interaction of cGMP with other cGMP-binding
proteins such as cGMP-dependent protein kinases.
Inhibition of gap junction permeability in the
follicle decreases cGMP in the oocyte
To investigate the effect of gap junction closure on cGMP in follicle-
enclosed oocytes, we applied the gap junction inhibitor
carbenoxolone (CBX) at 100 μM to follicles containing oocytes
expressing the cGi500 sensor. Under these conditions, CBX closes
gap junctions throughout the follicle by 1 hour and NEBD occurs at
1-2.5 hours (see Norris et al., 2008). At 1-1.5 hours after applying
CBX, cGMP in the oocyte had decreased to ~90 nM (Fig. 9A,C),
which would cause a ~4-fold increase in the cAMP-hydrolytic
activity of PDE3A.
Gap junction communication between the oocyte and somatic
cells can also be decreased by injection of follicle-enclosed oocytes
with an antibody that specifically recognizes connexin 37 (CX37;
GJA4 – Mouse Genome Informatics) (Norris et al., 2008), which is
the predominant connexin in the gap junctions between the oocyte
and cumulus cells (Simon et al., 1997). Like CBX, the CX37
antibody causes meiotic resumption (Norris et al., 2008). NEBD
occurs between 6 and 12 hours after injection; the lag time indicates
that the antibody most likely affects CX37 turnover, rather than
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Fig. 8. Decreasing cGMP by injecting follicle-enclosed oocytes
with the catalytic domain of PDE9A causes PDE3-dependent
meiotic resumption. (A,B) Time course of nuclear envelope
breakdown (NEBD) in response to injection of various concentrations of
(A) the catalytic domain of PDE9A or a catalytically inactive mutant
(D293A), or (B) the catalytic domain of PDE3A or BSA control.
(C) Meiotic resumption in response to injection of PDE9A is reversibly
inhibited by milrinone, an inhibitor of PDE3. Follicles were preincubated
for 1-2 hours with 100μM milrinone or with a control solution
containing 0.5% DMSO; then, the follicle-enclosed mouse oocytes
were injected with 180μg/ml PDE9A and observed for NEBD. Five
hours later, the follicles were washed into milrinone-free medium. Each
curve represents the results from injection of 7-14 follicle-enclosed
oocytes.
Fig. 9. cGMP concentrations in follicle-enclosed oocytes treated
with reagents that affect gap junction closure, and in follicle-
enclosed oocytes and whole follicles in response to LH. (A,B) The
YFP/CFP emission ratio from follicle-enclosed mouse oocytes containing
the cGMP sensor cGi500, before and after injecting 1 mM cGMP, for
follicles treated with 100μM CBX (A), or LH plus 10μM U0126 (B).
(C) cGMP concentrations in follicle-enclosed oocytes after various
treatments (see text), as determined from measurements as in A,B and
the calibration curve in Fig. 6C. The values for basal and 1-1.3 hour LH
conditions are from Fig. 6C. Oocytes had not undergone NEBD at the
time of the measurements. (D) cGMP concentrations in whole follicles
with or without treatment for 1 hour with LH (mean±s.e.m. for n












directly inhibiting channel permeability (Norris et al., 2008). In
accordance with the stimulation of meiotic resumption, the CX37
antibody (2 μM) caused a decrease in cGMP in the oocyte when
measured 5-6 hours after injection (Fig. 9C).
These results support the conclusion that diffusion from the
somatic cells to the oocyte of cGMP, or of a small molecule required
for cGMP accumulation, is required to maintain prophase arrest.
LH-induced closure of gap junctions inhibits this diffusion and is a
stimulus for meiotic resumption in the oocyte.
LH also causes cGMP to decrease in the oocyte by
a second pathway that is independent of gap
junction closure
LH signaling leads to meiotic resumption by two parallel pathways:
mitogen-activated protein kinase (MAPK)-dependent closure of gap
junctions via phosphorylation of connexin 43 (CX43; GJA1 –
Mouse Genome Informatics), which is the predominant connexin in
the gap junctions between the somatic cells, and another pathway
that is independent of both MAPK activation and the resulting gap
junction closure (Norris et al., 2008). The existence of this second
pathway was demonstrated by the finding that inhibition of MAPK
activation by 10 μM U0126 prevents LH-stimulated gap junction
closure but not meiotic resumption (Norris et al., 2008) (see Fig. S4
in the supplementary material).
To investigate whether LH can decrease oocyte cGMP levels
without closing gap junctions, we applied LH to follicles in the
presence of 10 μM U0126, and 1-1.5 hours later measured cGMP in
the follicle-enclosed oocytes. The cGMP concentration under these
conditions was ~30 nM, the same as that in follicle-enclosed oocytes
exposed to LH without U0126 (Fig. 9B,C). Thus, both of the
pathways by which LH causes meiotic resumption cause a decrease
in cGMP prior to NEBD.
LH decreases cGMP in the somatic cells of the
follicle
We next investigated whether the cGMP concentration in the
somatic cells of an unstimulated follicle is similar to that in the
oocyte, and whether LH causes a decrease in somatic cell cGMP that
could account for the gap junction closure-independent decrease in
oocyte cGMP. A decrease in cGMP concentration, to 40% of the
initial value, was previously reported in hamster follicles exposed to
LH (Hubbard, 1986).
In a mechanically isolated follicle, ~90% of the cellular volume
comprises the follicle itself, with the remainder comprising
adhering theca and interstitial cells that are not connected by gap
junctions to the follicle and are not considered to be part of the
follicle. These adhering cells cannot be removed without disrupting
the follicle. Within the follicle, ~99% of the ~20 nl cellular volume
is due to the somatic cells, compared with ~0.2 nl for the oocyte.
Therefore, determination of cGMP in isolated follicles provides an
approximate measurement of cGMP in the somatic cells of the
follicle.
Basal cGMP in isolated follicles was determined by
immunoassay to be ~2 μM, and 1 hour after applying LH it had
decreased to ~80 nM (Fig. 9D). Considering the different methods
of measurement that were used, and the contribution of
extrafollicular cells to the whole-follicle measurements, the values
that we obtained for cGMP in whole follicles and in follicle-
enclosed oocytes are similar (compare Fig. 9C with 9D). These
results support the conclusion that the decrease in cGMP in the
somatic cells of the follicle contributes, via gap junctions, to the
decrease in cGMP in the oocyte.
DISCUSSION
Monitoring cAMP and cGMP levels in intact
follicle-enclosed oocytes
Ovarian follicles are multicellular complexes that consist of oocytes
surrounded by somatic cells; all of these cells are interconnected by
dynamically regulated gap junctions and function together to
regulate meiosis in the oocyte. Here we have developed FRET-based
methods to measure concentrations of cytosolic cAMP and cGMP
in follicle-enclosed oocytes, allowing us to evaluate how cyclic
nucleotide-regulated enzymes function in a physiologically intact
tissue to control cell cycle progression.
cGMP from the somatic cells maintains meiotic
arrest in the oocyte by inhibiting PDE3A
Results described here demonstrate that elevated cGMP in the
oocyte is required to maintain prophase arrest, and that the
suppression of meiotic progression by cGMP is due to its inhibitory
effect on PDE3A hydrolysis of cAMP, thus keeping PKA active. The
somatic cells maintain the arrest by providing the oocyte with cGMP
through gap junctions (see Fig. 10). If guanylyl cyclases are present
at relatively high levels in the somatic cells, but at relatively low
levels in the oocyte, the oocyte would be dependent on the somatic
cells for its supply of cGMP; guanylyl cyclase agonists have
inhibitory effects on spontaneous meiotic resumption in cumulus-
oocyte complexes, but not in isolated oocytes, suggesting that this
is likely (Törnell et al., 1990b; Bu et al., 2004).
Cyclic AMP diffusion into the oocyte from the somatic cells could
also contribute to maintaining meiotic arrest (Anderson and
Albertini, 1976). However, this idea is difficult to reconcile with
evidence showing that when cAMP generation in the oocyte is
inhibited, by preventing the function of GPR3 or Gs in the oocyte,
cAMP from the somatic cells is insufficient to maintain cAMP in the
oocyte at a level that prevents meiotic resumption (Mehlmann et al.,
2002; Mehlmann, 2005b). The concentration of cAMP in the
somatic cells of an unstimulated follicle probably varies in different
microdomains; it appears to be low in regions that regulate PKA
(Hunzicker-Dunn, 1981; Panigone et al., 2008), but higher
elsewhere (Schultz et al., 1983; Hashimoto et al., 1985; Hsieh et al.,
2007). This issue requires further study. If a somatic cell-oocyte
cAMP gradient is present, selective permeability of CX37 for cGMP
over cAMP is a possible mechanism that could limit diffusion of
cAMP through the CX37 junctions at the surface of the oocyte.
Although the cGMP/cAMP permeability of CX37 has not been
investigated, some other gap junctions are known to be selectively
permeable to cGMP (Bevans et al., 1998; Locke et al., 2004).
LH lowers oocyte cGMP and stimulates meiotic
resumption by decreasing somatic cell cGMP and
gap junction permeability
Receptors for LH are present in the mural granulosa and theca cells,
but not in the cumulus cells or oocyte (Amsterdam et al., 1975). LH
receptor activation stimulates Gs and activates adenylyl cyclase
(Hunzicker-Dunn and Mayo, 2006), and as a consequence elevates
cAMP levels (Schultz et al., 1983; Hashimoto et al., 1985; Hsieh et
al., 2007) and PKA activity (Hunzicker-Dunn, 1981; Panigone et al.,
2008) in the mural granulosa cells. One way that the LH signal is
conveyed into the follicle interior is by the PKA-dependent release
of peptides that activate EGF receptors, which in turn activate
MAPK (Panigone et al., 2008). MAPK phosphorylates and thus
closes the CX43 gap junctions throughout the somatic compartment,
although the permeability of the CX37 gap junctions between the
cumulus cells and oocyte remains unchanged (Sela-Abramovich et











al., 2005; Sela-Abramovich et al., 2006; Norris et al., 2008). Our
results indicate that gap junction closure reduces the flux of cGMP
from the somatic cells to the oocyte (Fig. 10).
In addition, LH decreases somatic cell cGMP, such that less
cGMP would move from the somatic cells into the oocyte, even if
gap junctions remain open (Fig. 10). The decrease in cGMP in the
somatic cells could result from inhibition of a guanylyl cyclase or
from stimulation of a cGMP phosphodiesterase. There is some
evidence for regulation of the cyclase rather than the
phosphodiesterase (Patwardhan and Lanthier, 1984), although it
remains to be determined which particular guanylyl cyclases and/or
phosphodiesterases are involved, how they are regulated, and
whether interfering with LH-induced changes in their activity
prevents meiotic resumption. It is also unknown whether EGF
receptor activation functions in the pathway by which LH causes
cGMP levels to decrease in the somatic cells.
Mechanisms other than the decrease in cGMP might also
contribute to the decrease in oocyte cAMP in response to LH.
Evidence argues against regulation of cAMP production by
inhibition of GPR3/Gs signaling or stimulation of a Gi- or Ca2+-
mediated pathway in the oocyte (Mehlmann et al., 2006; Norris et
al., 2007), but cGMP-independent stimulation of PDE3A (Richard
et al., 2001; Han et al., 2006) or additional LH signaling pathways
(Eppig and Downs, 1987; Kalous et al., 2006; Chen and Downs,
2008; Kawamura et al., 2009) might function in parallel with cGMP
regulation. However, our results indicate that the decrease in cGMP
in the oocyte is sufficient to account for the stimulation of meiotic
resumption by LH.
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